CMND

Clearmind Medicine Inc. (CMND) ESG Analysis Analysis (2026)

Invetso Score: 5.6/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.4 (Moderate)

CMND’s near-zero debt intensity suggests limited balance-sheet pressure for environmental capex, but peers with stronger disclosure typically provide clearer transition planning.

Zero reported R&D intensity implies limited innovation spending visibility, which can constrain peer-relative progress on process efficiency and lower-carbon product development.

The provided metrics do not evidence material environmental leadership or lag, leaving CMND broadly in line with smaller peers that also disclose limited sustainability data.

Absent disclosed emissions, energy, or waste metrics, CMND’s environmental positioning cannot be distinguished from peers on operational footprint management.

Social

Score:

No workforce, safety, or turnover metrics are provided, so CMND’s social positioning remains opaque versus peers with more complete labor and human-capital disclosure.

Zero stock-based compensation intensity may indicate limited equity-based retention tools, which can weaken peer-relative alignment of employee incentives and long-term engagement.

The available data do not show material social controversies or structural workforce disadvantages, keeping CMND broadly neutral relative to peers.

Limited disclosure itself is a social governance signal, because peers with stronger reporting usually demonstrate better visibility into employee and community risk management.

Governance

Score:

CMND’s very low debt-to-equity ratio indicates conservative leverage, which reduces creditor pressure and supports governance flexibility versus more levered peers.

Net debt to EBITDA of 1.54x is manageable, suggesting less balance-sheet strain than peers with higher leverage and tighter covenant risk.

The absence of disclosed SBC and R&D spending limits assessment of capital-allocation discipline, but the provided metrics do not indicate aggressive dilution or leverage.

Overall governance appears modestly better than highly levered peers, yet limited disclosure prevents a stronger relative score.

Overall Score

Score:

CMND screens as a moderate ESG peer relative, with conservative leverage supporting governance while limited disclosure keeps environmental and social positioning indistinct.

Score Driver: Conservative Leverage Is The Clearest Relative Strength, Offset By Sparse ESG Disclosure Across Environmental And Social Dimensions.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Clearmind Medicine Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →